TIDMOSEC TIDMOSEC 
 
 
   Octopus AIM VCT 2 plc 
 
   Final Results 
 
   14 February 2017 
 
   Octopus AIM VCT 2 plc, managed by Octopus Investments Limited, today 
announces the final results for the year ended 30 November 2016. 
 
   These results were approved by the Board of Directors on 10 February 
2017. 
 
   You may view the Annual Report in full at www.octopusinvestments.com in 
due course. All other statutory information will also be found there. 
 
   Financial Summary 
 
 
 
 
                                                    30 November   30 November 
                                                        2016          2015 
 
Net assets (GBP'000s)                                     63,005        52,317 
Profit/(Loss) on ordinary activities for the year 
 after tax (GBP'000s)                                      3,184         4,047 
Net asset value ("NAV") per share                          80.6p         80.6p 
Ordinary Dividends per share - paid in year                 4.0p          4.0p 
Special Dividend per share - paid in year                      -          2.0p 
Final Dividend per share proposed*                          2.0p          2.0p 
Total Return**                                              5.0%          7.8% 
 
   * The proposed final dividend will, if approved by shareholders, be paid 
on 28 April 2017 to shareholders on the register on 24 March 2017. 
 
   **Total return is calculated as (movement in NAV + dividends paid in the 
period) divided by the NAV at the beginning of the period. 
 
   Chairman's Statement 
 
   Introduction 
 
   I would particularly like to welcome new shareholders who have joined 
the share register and I do hope that I will see some of you at the AGM 
on 20 April 2017. 
 
   The year to 30 November 2016 has not been quite the one we expected, 
with both domestic and international developments taking investors by 
surprise and causing some volatility. In the light of those events, the 
resilience of the market generally has also been surprising and, while 
my last annual statement was correct to comment on the potential for the 
derating of smaller companies while volatile market conditions persisted, 
it is encouraging to report that your Company has produced a positive 
return, helped particularly by the progress made by many of the maturing 
holdings in the portfolio. 
 
   Performance 
 
   The Net Asset Value on 30 November 2016 was 80.6p per share, which is in 
line with the 80.6p reported last year. Adding back the 4.0p of 
dividends paid in the year, to adjust the year end NAV to 84.6p, gives a 
total return of 5.0%. In the same twelve months, the FTSE All Share 
Index rose by 9.8%, the FTSE SmallCap (excluding investment companies) 
Index by 7.9% and the FTSE AIM All Share Index by 12.8%, all on a total 
return basis. 
 
   Last year I commented that positive performance contributions had come 
from the more established companies in the portfolio, with many of the 
smaller and yet to be profitable companies seeing their share prices 
struggle. This year was similar in many ways, with positive 
contributions to performance from many of the more mature companies in 
the portfolio, supplemented by good contributions from some of the newer 
and smaller companies which have begun to establish themselves in their 
respective marketplaces. Craneware, Abcam, RWS and Quixant are examples 
of more mature holdings, whilst Gear4music, DP Poland and Scientific 
Digital Imaging are examples of the newer holdings. 
 
   What is quite clear is that the timetable for success, or even partial 
success, is long. For example, since our first investment, DP Poland has 
needed additional capital and made several alterations to its retail 
format before achieving its initial success, and the consequent share 
price increase of the last year. As ever this just goes to prove that it 
is the determination of the management team that is crucial to making 
any company a successful investment. 
 
   In the year under review AIM has raised GBP5.0 billion of new capital, 
fulfilling its purpose of providing additional growth capital for its 
members. 
 
   New VCT Regulations 
 
   It is a little over a year now since the latest VCT regulations began to 
take effect. With the publication of guidance notes by HMRC more 
recently the new structure of the market is starting to take effect and 
our Managers are acclimatising to the new environment. At this stage 
there has been little impact on the portfolio itself and no need to 
change investment policies. That is a situation that may change in the 
future, but any change is much more likely to be evolutionary rather 
than immediately dramatic. At present there are signs of a developing 
trend towards investing in smaller and earlier stage companies which fit 
the HMRC regulations. These may take a few years to contribute 
meaningfully to performance, not least because the companies will 
invariable require additional capital. 
 
   Making follow-on investments has proved difficult on occasions and is 
one concern for the sector as a whole, which needs to be addressed by 
the authorities, since the inability to support existing investments 
seems to invalidate much of the purpose of VCTs and to undermine the 
potential for growth in the UK economy. 
 
   Dividends 
 
   The Board has a policy of providing shareholders with a yield of 5%, 
subject to a minimum payment of 3.6p per year. In September an interim 
dividend of 2.0p was paid to all shareholders. The Board is recommending 
a final dividend in respect of the year to 30 November 2016 of 2.0p per 
share, making 4.0p in total. This is in line with the yield objective. 
Subject to the approval of shareholders at the AGM the dividend will be 
paid on 28 April 2017 to shareholders on the register on 24 March 2017. 
 
   Dividend Reinvestment Scheme 
 
   In common with a number of other VCTs in the industry, your Company has 
established a Dividend Reinvestment Scheme (DRIS) following approval at 
the AGM in 2014.  Some shareholders have already taken advantage of this 
opportunity.  For investors who do not need income, but value the 
additional tax relief on their reinvested dividends, this is an 
attractive scheme and I hope that more shareholders will find it useful. 
In the course of the year 395,968 new shares have been issued under this 
scheme, returning GBP0.3 million to the Company. The dividend referred 
to above will be eligible for the DRIS. 
 
   Share Buybacks 
 
   During the year to 30 November 2016 your Company continued to buy back 
shares in the market from selling shareholders and purchased 1,888,104 
ordinary shares for a total consideration of GBP1,401,000. We have 
maintained a discount of approximately 4.5% (equating to a 5.0% discount 
to the selling shareholder after costs), which your Board monitors and 
intends to retain as a policy which fairly balances the interests of 
both remaining and selling shareholders. Buybacks remain an essential 
practice for VCTs as providing a means of selling is an important part 
of the initial investment decision and has enabled your Company to grow. 
As such therefore I hope you will all support the appropriate resolution 
at the AGM. 
 
   Share Issues 
 
   A prospectus was issued on 21 December 2015 and the final issue of 
shares under that prospectus was made in October 2016, raising a total 
of GBP11.5 million after costs in the year. This brings the total 
proceeds from share issues, including the DRIS, to GBP11.8 million. The 
Board has announced a Top-Up offer to raise up to a further GBP4.3 
million. This small issue allows existing investors a new chance to 
invest and does not need a prospectus. 
 
   Risks and Uncertainties 
 
   In accordance with the Listing Rules and the Companies Act 2006 under 
which your Company operates, your Board has to comment on potential 
risks and uncertainties, which could have a material impact on the 
Company's performance.  A risk arises from the requirement to maintain 
compliance with HMRC regulations requiring 70% of your Company's assets 
to be invested in qualifying holdings. Other risks include economic 
conditions, which impact particularly on smaller companies in which your 
Company invests, and this could have an adverse impact on share prices. 
 
   VCT Status 
 
   PricewaterthouseCoopers LLP provides your Board and Investment Manager 
with advice concern continuing compliance with HMRC regulations for 
VCTs. Your Board has been advised that the Company is in compliance with 
the conditions laid down by HMRC for maintaining approval as a VCT.  A 
key requirement is to maintain at least 70% qualifying investment level. 
As at 30 November 2016 over 85% of the portfolio, as measured by HMRC 
regulations, was invested in qualifying investments. 
 
   Annual General Meeting 
 
   The Annual General Meeting will be held on 20 April 2017.  I very much 
hope that you will be able to come.  After the formal business, our 
Investment Managers will make a presentation and there will, of course, 
be a chance for you to ask questions. At the Annual General Meeting, a 
resolution will be proposed to extend the life of the Company until 2022 
in order to preserve the VCT status of the Company for the benefit of 
both existing shareholders and new investors participating in the 
current share offer. 
 
   Outlook 
 
   The market extended its year end rally to reach new highs in the middle 
of January, helped by some upward revisions of growth statistics which 
have allayed some of the fears about the early effects of the Referendum 
result on the economy.  However, uncertainty continues to be the 
dominant theme, with the lack of clarity regarding the terms of our exit 
from the EU and a new President entering the White House both likely to 
impact market sentiment as the year unfolds. 
 
   The portfolio now contains 69 holdings across a range of sectors and 
many of them have already demonstrated their management's ability to 
grow their businesses successfully in difficult economic conditions. 
The balance of the portfolio towards profitable companies remains, and 
the cash available for new investments will allow us to take advantage 
of any future weakness in valuations should it occur. With the VCT over 
85% invested in qualifying companies for HMRC purposes your Manager can 
afford to be selective about new investments. 
 
   Keith Mullins 
 
   Chairman 
 
   10 February 2017 
 
   Investment Manager's Review 
 
   Introduction 
 
   In a year, in which some significant economic and political events have 
taken markets by surprise, the expectation that volatility would follow 
as a consequence has been confounded by a stronger market, particularly 
towards the end of the year to 30 November 2016. Although larger 
companies, as measured by the FTSE 100 Share Index have, on balance, 
performed in absolute terms a little better than smaller companies, all 
indices have risen. Large companies with overseas earnings had a 
particularly strong period of performance post the Referendum in June as 
Sterling fell and the oil price began to recover.  There have been some 
notable contributors to the portfolio, both positive and negative, but 
we are pleased to report a resilient NAV performance and the maintenance 
of the 5% yield objective. 
 
   The year to 30 November 2016 has continued to see AIM raise new capital 
for companies, both already quoted and new flotations, and your Company 
has invested steadily throughout the year as well as raising new capital 
for future investments. The prospectus offer closed in October 2016 and 
we have recently announced a 'Top-Up offer of up to GBP4.3 million to 
give existing and new shareholders a chance to invest in the current tax 
year. Early in the new year we expect to see a number of VCT qualfifying 
investment opportunities, which have chosen to postpone their 
fundraising from December. 
 
   The Alternative Investment Market 
 
   Despite some volatility in the first half, the FTSE AIM All-Share Index 
was little changed in that period.  However, in the second six months 
the index rose markedly, helped by a resurgence in resource and oil 
stocks. Share trading volumes also picked up helped by a sense of 
stability if not outright confidence, despite the result of the 
Referendum to leave the EU, and by smaller companies continuing to be 
seen as an attractive asset class.  In addition, September saw a 
reasonable results season confirming that for many smaller companies the 
economy remained supportive. Against that background the number of AIM 
companies has shrunk further, to 993 at 30 November 2016, compared to 
1,049 a year earlier. However, we believe that the quality has continued 
to rise and see nothing fundamentally wrong with AIM just because it has 
fewer companies on the market. New issues in the last twelve months 
include such names as Joules, the clothing manufacturer and retailer, 
and Hotel Chocolat, the chocolatier. AIM is certainly not a second class 
market, but is still best described as a collection of smaller growth 
companies. 
 
   Those companies have continued to raise new capital throughout the year. 
In the twelve months to 30 November 2016 AIM raised a further GBP3.6 
billion of new capital for existing companies and a total of GBP1.4 
billion for new companies floating on the market. Although the level of 
fundraising for existing companies was lower than last year, these 
figures show conclusively that AIM remains open for the funding of good 
growth companies and continues to attract new entrants. VCTs play a 
significant part in that funding process and we identify below the 
companies we have invested in during the second half of the year. 
 
   Performance 
 
   Adding back dividends paid in the year  to show the total return, the 
Net Asset Value increased in the year by exactly the same amount as the 
dividends paid out, giving a total return of 5.0%, a progression on the 
0.6% achieved in the first half. This compares with a total return for 
the FTSE Smallcap Index of 7.9% and for AIM of 12.8%, and the FTSE All 
Share Index of 9.8%. Individual months in the year under review saw 
share prices suffering significant bouts of volatility and the market 
has generally remained wary of smaller companies that have yet to make a 
profit although more established companies outperforming expectations 
have been well rewarded by rising prices. 
 
   Within the portfolio there was once again a good contribution from the 
more established and already profitable companies which includes many of 
the individual non-qualifying holdings such as RWS, Abcam, Next Fifteen 
and Gooch and Housego. However, the polarisation we talked about in the 
interim statement persisted with companies deemed to be exposed to the 
'Brexit effect' such as Staffline and Vertu Motors continuing to 
underperform despite producing decent figures and encouraging trading 
statements.  In addition Tasty's exposure to rising costs caused it to 
re-evaluate some of its new opening pipeline and raise extra funds to 
reduce its debt financing, all of which caused its shares to 
underperform.  We do not share the market's current pessimism about 
these companies which have been held in the portfolio for a number of 
years and where the management teams have successfully grown in 
challenging economic conditions in the past. We believe that their share 
prices will recover as they deliver on their growth plans. 
 
   Elsewhere, underperformance came from the earlier stage companies in the 
portfolio, particularly those that had setbacks or showed themselves in 
need of further cash to reach profitability. Nektan, Oxford 
Pharmascience and Microsaic all performed very  badly in the year. 
Nektan has raised money post the period end and Microsaic had a 
fundraising where we made a further investment to support the new 
management team who believe they now have a product that they can sell. 
Oxford Pharmascience is trading at around the GBP22m value of cash in 
the balance sheet reflecting disappointment that it has so far failed to 
negotiate a licensing deal for its taste masking technology for NSAIDS. 
The other poor performers were TLA where the bid and move to Nasdaq that 
had boosted the shares in the first half of the year went away and 
Escher which underwent significant changes to its board. 
 
   There were several corporate developments. Breedon completed the 
acquisition of Hope, doubling the size of the business and giving it a 
much prized cement railhead into London, supporting another year of good 
share price performance. GB Group also made an important acquisition in 
scanning technology although its shares suffered a setback on the news 
that revenue growth would be affected by the slow roll-out of a UK 
Government contract.  The shares have since recovered most of their 
losses reflecting appreciation of the strength of the Group's growth 
opportunities as remote identity checking becomes more important. 
Ergomed raised money and acquired another pharmacovigilance business in 
a very earnings enhancing deal which was much better received by the 
market than its earlier acquisition of Haemostatix, and the shares have 
started to recover.  Midatech also reacted well to news of a GBP10m 
fundraising which should finanace the business to profitability. Idox, 
EKF and Animalcare were all positive contributors to performance after 
their core businesses started to show growth after a period of 
consolidation. In EKF's case this was after the business was pared back 
to its core and re-focussed under the direction of the new Chairman. 
 
   Several shares performed particularly well as the underlying businesses 
demonstrated that they were delivering on, or ahead of, their plans at 
the time that we invested.  Gear4music is now a profitable business with 
a third of its revenues coming from Europe and growing at more than 50% 
in the current year.  DP Poland has also finally demonstrated that the 
Domino's model works in Poland and is now signing up sub-franchisees for 
new sites.  Quixant has also increased its customer base and has had 
several upgrades to its forecasts this year, making it the biggest 
positive contributor to the fund's performance this year. Craneware has 
also re-established its growth credentials although it has had more of a 
roller-coaster performance as it outperformed on the back of weak 
sterling before underperforming on fears over changes to the US 
healthcare market under Trump. 
 
   The non-qualifying element of the equity portfolio also did well in the 
year as our existing strategy of investing in larger more liquid, 
profitable companies to counterbalance new earlier stage qualifying 
holdings continued to pay off. We have now supplemented these with 
holdings in Octopus Portfolio Manager and the FP Octopus Micro Cap 
Growth funds to manage liquidity while cash is awaiting investment. 
 
   Portfolio Activity 
 
   Having made two new qualifying investments in the first half of the year, 
we added three further new qualifying holdings at a cost of GBP0.66m as 
well as one further qualifying investment of GBP0.34 million into Futura 
Medical, an existing holding, in the second half. This made a total 
investment of GBP1.96 million in qualifying investments in the year 
which was considerably lower than last years GBP4.78 million reflecting 
slightly lower levels of fundraising activity on AIM and the short term 
effects of digesting the new rules.  Of the three new qualifying 
investments, two were new issues.  LoopUp is a telephone and web 
conferencing operator with an easy to use system with more functionality 
than many market competitors.  It is growing rapidly, and although not 
profitable at the time of float, it made an interim  profit and is 
expected to be so for the year to December.  FreeAgent is a supplier of 
cloud based accounting software sold as  a service to enable small 
businesses to file their tax returns on line or via mobile.  It is 
expected to be profitable for the year to March 2019. 
 
   There were no major sales in the year although we took the opportunity 
to dispose of some of the smaller holdings that were not contributing to 
performance, mostly at a loss. The largest sale was Vianet where the 
market for its beer monitoring device continues to be difficult and the 
holdings in Lombard Medical and Altitude Group were also sold.  In all 
disposals raised GBP1.2 million in cash. 
 
   New VCT Regulations 
 
   Almost coinciding with the last year end the Summer Budget of 2015 
received the Royal Assent and with guidelines published by HMRC at about 
the same time as the interim results in May 2016, it has been a period 
of assimilating the consequences of the new regulations. We do not 
believe that there needs to be any material change to our investment 
approach.  We are determined to maintain a threshold of quality and to 
invest where we see returns from growth. However, the emphasis of the 
new regulations is definitely to encourage investment into earlier stage 
companies and to that extent, it seems likely over a number of years, 
that the portfolio will see a rise in the number of smaller companies 
receiving our initial investment.  We would expect to invest further in 
those companies as they grow and would certainly seek to reduce the risk 
in those initial investments by not investing as much as perhaps we 
might have done a year or two ago, when quite possibly our investment 
would have been on the last occasion that a VCT could invest. 
 
   At present there has been little change to the portfolio, as we continue 
to hold the larger market capitalisation companies, in which we invested 
several years ago as qualifying companies, or which we bought in the 
market prior to the rule changes. 
 
   To summarise the changes, in order to qualify companies must: 
 
 
   -- have fewer than 250 full time equivalent employees; and 
 
   -- have less than GBP15 million of gross assets at the time of investment 
      and no more than 
 
   -- GBP16 million immediately post investment; and 
 
   -- be less than seven years old from the date of its first commercial sale 
      (or 10 years if a knowledge intensive company) if raising State Aided (ie 
      VCT) funds for the first time; and 
 
   -- have raised no more than GBP5 million of State Aided funds in the 
      previous 12 months and less than the lifetime limit of GBP12 million (or 
      GBP20 million if a knowledge intensive company); and 
 
   -- produce a business plan to show that its funds are being raised for 
      growth and development. 
 
 
   Although there is a longer period and higher funding limit allowed for 
knowledge intensive companies, it seems quite likely that a new funding 
gap will open up for smaller companies that hit their funding limit, but 
which are still in a development phase.  This would particularly affect 
a company that has failed for whatever reason to qualify as a knowledge 
intensive one. It is also possible that capital intensive companies, 
which potentially form a key part of the new government's industrial 
strategy, will face a funding chasm as VCTs will not be able to follow 
on with further investment and the companies may be too small to attract 
investment from more conventional and larger institutional investors. 
Accessing funds from the general public may also prove difficult since 
crowd funding seems reliant on tax breaks, which would not apply. This 
financing issue is probably a long way down any government department's 
list of priorities, but it is to be hoped that the funding gap fails to 
materialise for any of our holdings. One of our major and consistent 
reasons for refusing to invest is the belief that a company is not 
raising enough capital at a particular time.  We will persist with that 
criterion. 
 
 
   Outlook 
 
   Markets have enjoyed a surprisingly strong finish to 2016, buoyed by 
better than expected economic growth figures and a sense of relief that 
the immediate disaster predicted by those opposing the decision to exit 
the European Union has not materialised. However, political and 
macro-economic issues remain and newspaper headlines are still dominated 
by speculation about Brexit's likely depressing effect on our economy in 
the medium term as well as the shape of our eventual relationship with 
Europe and the rest of the world. These questions are unlikely to be 
settled quickly and it seems therefore that investors have to be 
prepared for continued bouts of uncertainty and volatility. However, the 
majority of news from the portfolio has continued to be encouraging in 
the run up to the end of 2016. 
   The portfolio now contains 69 holdings with investments across a range 
of sectors including several such as Craneware, Gooch and Housego, 
Gear4music, Clinigen, Cello, DP Poland and GB Group that have 
significant international exposure. Domestic companies such as Breedon, 
Vertu and Staffline have already demonstrated their management's ability 
to grow their businesses successfully in difficult economic conditions 
and the latter two should see scope for share price recovery if they 
continue to meet market expectations.  The balance of the portfolio 
towards profitable companies remains, with several expected to start 
paying dividends in 2017.  A top-up fundraising for GBP4.3 million will 
add to the funds available for new investments and allow us to take 
advantage of any dip in valuations should sentiment weaken in the 
future. We remain selective when viewing new investment opportunities. 
 
   The AIM Team 
 
   Octopus Investments Limited 
 
   10 February 2017 
 
   Directors' Responsibility Statement 
 
   The Directors are responsible for preparing the Annual Report and the 
financial statements in accordance with applicable law and regulations. 
 
   Company law requires the Directors to prepare financial statements for 
each financial year. Under that law the Directors have elected to 
prepare the financial statements in accordance with the Financial 
Reporting Standard applicable in the United Kingdom and Republic of 
Ireland ("FRS 102"). Under company law the Directors must not approve 
the financial statements unless they are satisfied that they give a true 
and fair view of the state of affairs of the Company and of the profit 
or loss of the Company for that period. 
 
   In preparing these financial statements the Directors are required to: 
 
 
   -- select suitable accounting policies and then apply them consistently; 
 
   -- make judgments and accounting estimates that are reasonable and prudent; 
 
   -- state whether applicable UK accounting standards have been followed, 
      subject to any material departures disclosed and explained in the 
      financial statements; and 
 
   -- prepare the financial statements on the going concern basis unless it is 
      inappropriate to presume that the Company will continue in business; 
 
   -- prepare a strategic report, a Directors' report and Directors' 
      remuneration report which comply with the requirements of the Companies 
      Act 2006. 
 
 
   The Directors are responsible for keeping adequate accounting records 
that are sufficient to show and explain the Company's transactions, to 
disclose with reasonable accuracy at any time the financial position of 
the Company and to enable them to ensure that the financial statements 
comply with the Companies Act 2006. They are also responsible for 
safeguarding the assets of the Company and hence for taking reasonable 
steps for the prevention and detection of fraud and other 
irregularities. 
 
   The Directors are responsible for ensuring that the Annual Report and 
accounts, taken as a whole, are fair, balanced, and understandable and 
provides the information necessary for shareholders to assess the 
group's performance, business model and strategy. 
 
   The Directors are responsible for ensuring the Annual Report and the 
financial statements are made available on a website.  Financial 
statements are published on the company's website in accordance with 
legislation in the United Kingdom governing the preparation and 
dissemination of financial statements, which may vary from legislation 
in other jurisdictions.  The maintenance and integrity of the company's 
website is the responsibility of the Directors.  The Directors' 
responsibility also extends to the ongoing integrity of the financial 
statements contained therein. 
 
   Directors' responsibilities pursuant to DTR4 
 
   The Directors confirm to the best of their knowledge: 
 
 
   -- the financial statements, prepared in accordance with the Financial 
      Reporting Standard applicable in the United Kingdom and Republic of 
      Ireland ("FRS 102"), give a true and fair view of the assets, liabilities, 
      financial position and profit and loss of the Company; and 
 
   -- the Annual Report includes a fair review of the development and 
      performance of the business and the financial position of the Company, 
      together with a description or the principal risks and uncertainties that 
      it faces. 
 
 
   On Behalf of the Board 
 
   Keith Mullins 
 
   Chairman 
 
   10 February 2017 
 
   Income Statement 
 
 
 
 
                      Year to 30 November 2016    Year to 30 November 2015 
                    Revenue   Capital    Total    Revenue   Capital    Total 
                    GBP'000   GBP'000   GBP'000   GBP'000   GBP'000   GBP'000 
 
Gain on disposal 
 of fixed asset 
 investments               -       300       300         -       172       172 
 
Gain on valuation 
 of fixed asset 
 investments               -     3,389     3,389         -     4,555     4,555 
 
Gain on valuation 
 of current asset 
 investments               -       174       174         -         -         - 
 
Investment Income        597         -       597       547         -       547 
 
Investment 
 management fees       (225)     (676)     (901)     (230)     (689)     (919) 
 
Other expenses         (375)         -     (375)     (308)         -     (308) 
Return on ordinary 
 activities before 
 tax                     (3)     3,187     3,184         9     4,038     4,047 
 
Taxation on return 
on ordinary 
activities                 -         -         -         -         -         - 
 
Return on ordinary 
 activities after 
 tax                     (3)     3,187     3,184         9     4,038     4,047 
 
Earnings per share  0.0p      4.5p      4.5p      0.0p      6.6p      6.6p 
 - basic and 
 diluted 
 
 
 
   There is no other comprehensive income for the period. 
 
 
   -- the 'Total' column of this statement represents the statutory income 
      statement of the Company; the supplementary revenue return and capital 
      return columns have been prepared in accordance with the AIC Statement of 
      Recommended Practice 
 
   -- all revenue and capital items in the above statement derive from 
      continuing operations 
 
   -- the Company has only one class of business and derives its income from 
      investments made in shares and securities and from bank and money market 
      funds, as well as OEIC funds. 
 
 
   Balance Sheet 
 
 
 
 
                             As at 30 November 2016     As at 30 November 2015 
                              GBP'000      GBP'000      GBP'000      GBP'000 
 
Fixed asset investments*                      49,737                    44,968 
Current assets: 
Investments*                     10,594                     5,397 
Debtors                              49                        54 
Cash at bank                      2,984                     2,010 
                                 13,627                     7,461 
Creditors: amounts falling 
 due within one year              (359)                     (112) 
Net current assets                            13,268                     7,349 
 
Net assets                                    63,005                    52,317 
 
Called up equity share 
 capital                                           8                         6 
Share premium                                 23,405                    11,575 
Special distributable 
 reserve                                      30,513                    34,841 
Capital reserve realised                    (10,168)                   (8,373) 
Capital reserve unrealised                    19,388                    14,406 
Revenue reserve                                (141)                     (138) 
Total equity shareholders' 
 funds                                        63,005                    52,317 
Net asset value per share                      80.6p                     80.6p 
 - basic and diluted 
 
 
 
   *Held at fair value through profit and loss 
 
   The statements were approved by the Directors and authorised for issue 
on 10 February 2017 and are signed on their behalf by: 
 
   Keith Mullins 
 
   Chairman 
 
   Company No: 05528235 
 
   Statement of changes in Equity 
 
 
 
 
                                                 Capital 
                                     Special     reserve    Capital 
                 Share    Share   distributable     -      reserve -   Revenue 
                Capital  Premium    reserves     realised  unrealised  reserve   Total 
                GBP'000  GBP'000     GBP'000     GBP'000    GBP'000    GBP'000  GBP'000 
As at 1 
 December 
 2014                 6    8,979         34,183  (10,457)      12,452    (147)   45,016 
Comprehensive 
income for the 
year: 
Management fee 
 allocated as 
 capital 
 expenditure          -        -              -     (689)           -        -    (689) 
Current year 
 gains on 
 disposal             -        -              -       172           -        -      172 
Current period 
 gains on fair 
 value of 
 investments          -        -              -         -       4,555        -    4,555 
Loss on 
 ordinary 
 activities 
 after tax            -        -              -         -           -        9        9 
Total 
 comprehensive 
 income for 
 the year             -        -              -     (517)       4,555        9    4,047 
Contributions 
by and 
distributions 
to owners: 
Repurchase and 
 cancellation 
 of own 
 shares               -        -          (925)         -           -        -    (925) 
Issue of 
 shares               -    8,320              -         -           -        -    8,320 
Share issue 
 costs                -    (362)              -         -           -        -    (362) 
Dividends paid        -        -        (3,779)         -           -        -  (3,779) 
Total 
 contributions 
 by and 
 distributions 
 to owners                 7,958        (4,704)         -           -        -    3,254 
Other 
Movements: 
Cancellation 
 of share 
 premium              -  (5,362)          5,362         -           -        -        - 
Prior years' 
 holding gains 
 now realised         -        -              -     2,601     (2,601)        -        - 
Total other 
 movements            -  (5,362)          5,362     2,601     (2,601)        -        - 
Balance as at 
 30 November 
 2015                 6   11,575         34,841   (8,373)      14,406    (138)   52,317 
 
 
 
 
                                                 Capital 
                                     Special     reserve    Capital 
                 Share    Share   distributable     -      reserve -   Revenue 
                Capital  Premium    reserves     realised  unrealised  reserve   Total 
                GBP'000  GBP'000     GBP'000     GBP'000    GBP'000    GBP'000  GBP'000 
As at 1 
 December 
 2015                 6   11,575         34,841   (8,373)      14,406    (138)    52,317 
Comprehensive 
income for the 
year: 
Management fee 
 allocated as 
 capital 
 expenditure          -        -              -     (676)           -        -     (676) 
Current year 
 gains on 
 disposal             -        -              -       300           -        -       300 
Current period 
 gains on fair 
 value of 
 investments          -        -              -         -       3,563        -     3,563 
Profit on 
 ordinary 
 activities 
 after tax            -        -              -         -           -      (3)       (3) 
Total 
 comprehensive 
 income for 
 the year             -        -              -     (376)       3,563      (3)     3,184 
Contributions 
by and 
distributions 
to owners: 
Repurchase and 
 cancellation 
 of own 
 shares               -        -        (1,401)         -           -        -   (1,401) 
Issue of 
 shares               2   12,367              -         -           -        -    12,369 
Share issue 
 costs                -    (537)              -         -           -        -     (537) 
Dividends paid        -        -        (2,927)         -           -        -   (2,927) 
Total 
 contributions 
 by and 
 distributions 
 to owners            2   11,830        (4,328)         -           -        -     7,504 
Other 
Movements: 
Prior years' 
 holding 
 losses now 
 realised             -        -              -   (1,419)       1,419        -         - 
Total other 
 movements            -        -              -   (1,419)       1,419        -         - 
Balance as at 
 30 November 
 2016                 8   23,405         30,513  (10,168)      19,388    (141)    63,005 
 
 
   Cash Flow Statement 
 
 
 
 
                            Year to 30 November 2016  Year to 30 November 2015 
                                     GBP'000                   GBP'000 
 
Cash flows from operating 
activities 
Return on ordinary 
 activities before tax                         3,184                     4,047 
Adjustments for: 
Decrease in debtors                                5                       343 
Decrease in creditors                            247                         5 
Gain/(loss) on disposal of 
 fixed assets                                  (300)                     (172) 
(Gain)/loss on valuation 
 of fixed asset 
 investments                                 (3,389)                   (4,555) 
(Gain)/loss on valuation 
 of current asset 
 investments                                   (174)                         - 
Cash from operations                           (427)                     (332) 
Income taxes paid                                  -                         - 
Net cash generated from 
 operating activities                          (427)                     (332) 
 
Cash flows from investing 
activities 
Purchase of fixed asset 
 investments                                 (2,261)                   (8,883) 
Sale of fixed asset 
 investments                                   1,181                     5,387 
Purchase of current asset 
 investments                                 (6,000)                         - 
Total cash flows from 
 investing activities                        (7,080)                   (3,496) 
 
Cash flows from financing 
activities 
Purchase of own shares                       (1,401)                     (925) 
Issue of own shares                           11,832                     7,958 
Dividends paid                               (2,927)                   (3,779) 
Total cash flows from 
 financing activities                          7,504                     3,254 
 
Increase in cash and cash 
 equivalents                                     (3)                     (574) 
 
Opening cash and cash 
 equivalents                                   7,407                     7,981 
 
Closing cash and cash 
 equivalents                                   7,404                     7,407 
 
Cash at bank                                   2,984                     2,010 
Money Market Funds                             4,420                     5,397 
Total cash and cash 
 equivalents                                   7,404                     7,407 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Octopus AIM VCT 2 plc via Globenewswire 
 
 
  http://www.octopusinvestments.com 
 

(END) Dow Jones Newswires

February 14, 2017 11:33 ET (16:33 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Octopus Aim Vct 2 (LSE:OSEC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Octopus Aim Vct 2 Charts.
Octopus Aim Vct 2 (LSE:OSEC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Octopus Aim Vct 2 Charts.